Niche Biologics AB Biosciences specializes in antibody-based biologics for diagnostic and therapeutic applications, presenting a clear entry point for collaborations on custom proteins, panels, and immuno-oncology research tools.

Early Stage Growth With a small team and revenue in the low to mid single digits, there is opportunity for strategic partnerships, contract development, and outsourced R&D services to scale capabilities and revenue efficiency.

Academic Ties Active engagement with interns and a Massachusetts-based ecosystem positions ABB to leverage university collaborations, joint research programs, and grant-supported projects that can expand product validation and visibility.

Therapeutic Pipeline Core competence in immuno-oncology biologics and the PRIM program indicates potential sell-in opportunities for niche therapeutic candidates, platform licensing, and co-development deals with biopharma interests.

Diagnostic Tools A panel of immune-related protein reagents as investigational tools creates cross-selling avenues to research labs and diagnostic developers seeking validated assay components and custom reagent solutions.